Mahamaya Lifesciences Management
Management criteria checks 2/4
Mahamaya Lifesciences' CEO is Krishnamurthy Ganesan, appointed in Sep 2024, has a tenure of 1.17 years. directly owns 21.86% of the company’s shares, worth ₹595.28M. The average tenure of the management team and the board of directors is 1.2 years and 6.1 years respectively.
Key information
Krishnamurthy Ganesan
Chief executive officer
₹7.9m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 1.2yrs |
| CEO ownership | 21.9% |
| Management average tenure | 1.2yrs |
| Board average tenure | 6.1yrs |
Recent management updates
No updates
Recent updates
CEO
Krishnamurthy Ganesan (75 yo)
Mr. Krishnamurthy Ganesan is MD of Mahamaya Life Sciences Private Limited from September 1, 2024 and Director since May 07, 2002. He holds a degree of Bachelor of Science in Chemistry from University of Ma...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Director | 1.2yrs | ₹7.91m | 21.86% ₹ 595.3m | |
| CFO & Executive Director | 1.4yrs | ₹11.11m | 17.61% ₹ 479.5m | |
| Company Secretary & Compliance Officer | 1yr | ₹731.00k | no data | |
| Whole-Time Director | no data | ₹5.92m | 16.88% ₹ 459.7m | |
| VP of Plant Operations & Operational Head | no data | no data | no data | |
| Assistant Vice President of Finance & Accounts | 1.2yrs | no data | no data | |
| Commercial Head & VP of Commercial Operations | no data | no data | no data |
Experienced Management: 544611's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Director | 23.5yrs | ₹7.91m | 21.86% ₹ 595.3m | |
| CFO & Executive Director | 11.3yrs | ₹11.11m | 17.61% ₹ 479.5m | |
| Whole-Time Director | 23.5yrs | ₹5.92m | 16.88% ₹ 459.7m | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | less than a year | no data | no data |
Experienced Board: 544611's board of directors are considered experienced (6.1 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/25 22:13 |
| End of Day Share Price | 2025/11/25 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Mahamaya Lifesciences Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.